Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy

被引：0
|
作者：
Kang, Zhihua
Fu, Pan
Ma, Hui
Li, Tao
Lu, Kevin
Liu, Juan
Ginjala, Vasudeva
Romanienko, Peter
Feng, Zhaohui
Guan, Ming
Ganesan, Shridar
Xia, Bing
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7106
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease
    Zheng, Yan
    Liu, Aiyi
    Wang, Zi-Jun
    Cao, Qing
    Wang, Wei
    Lin, Lin
    Ma, Kaijie
    Zhang, Freddy
    Wei, Jing
    Matas, Emmanuel
    Cheng, Jia
    Chen, Guo-Jun
    Wang, Xiaomin
    Yan, Zhen
    BRAIN, 2019, 142 : 787 - 807
  • [22] Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2
    Ang, Gareth Chin Khye
    Gupta, Amogh
    Surana, Uttam
    Yap, Shirlyn Xue Ling
    Taneja, Reshma
    CANCERS, 2022, 14 (12)
  • [23] Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer
    Hung, Wen-Chun
    Pan, Mei-Ren
    Hsu, Ming-Chuan
    Chen, Li-Tzong
    Shan, Yan-Shen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 245 - 245
  • [24] A novel EHMT1 variant in a Turkish case with Kleefstra Syndrome
    Ersoy, Aysenur
    Geckinli, Bilgen Bilge
    Baser, Zeynep
    Hanoglu, Onur
    Kapazan, Cekdar
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1105 - 1105
  • [25] Biochemical validation of EHMT1 missense mutations in Kleefstra syndrome
    Yamada, Ayumi
    Shimura, Chikako
    Shinka, Yoichi
    JOURNAL OF HUMAN GENETICS, 2018, 63 (05) : 555 - 562
  • [26] Biochemical validation of EHMT1 missense mutations in Kleefstra syndrome
    Ayumi Yamada
    Chikako Shimura
    Yoichi Shinkai
    Journal of Human Genetics, 2018, 63 : 555 - 562
  • [27] Targeting EHMT2/G9a for cancer therapy: Progress and perspective
    Jan, Suraya
    Dar, Mohd Ishaq
    Wani, Rubiada
    Sandey, Jagjeet
    Mushtaq, Iqra
    Lateef, Sammar
    Syed, Sajad Hussain
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 893
  • [28] Histone methyltransferase EHMT2 is a potential therapeutic target in endometrioid ovarian cancer
    Tanimoto, Saki
    Sone, Kenbun
    Ishizaka, Aya
    Suzuki, Eri
    Hachijo, Ryuta
    Toyohara, Yusuke
    Fukuda, Tomohiko
    Taguchi, Ayumu
    Miyamoto, Yuichiro
    Tanikawa, Michihiro
    Oda, Katsutoshi
    Maruyama, Reo
    Osuga, Yutaka
    CANCER SCIENCE, 2023, 114 : 917 - 917
  • [29] EHMT2 suppresses the variation of transcriptional switches in the mouse embryo
    Zeng, Tie-Bo
    Pierce, Nicholas
    Liao, Ji
    Singh, Purnima
    Lau, Kin
    Zhou, Wanding
    Szabo, Piroska E.
    PLOS GENETICS, 2021, 17 (11):
  • [30] Cell consequences of loss of function of the epigenetic factor EHMT1
    Iglesias-Ortega, Lucia
    Megias-Fernandez, Clara
    Dominguez-Gimenez, Paloma
    Jimeno-Gonzalez, Silvia
    Rivero, Sabrina
    CELLULAR SIGNALLING, 2023, 108
12345